(Date:11/19/2009)...AM, Mass., Nov. 19 Arlington Medic...t the leading driver of antibiotic selection in no...ivity against gram-positive and gram-negative path...use nosocomial pneumonia, surveyed European physic...at provide appropriate coverage against common pat...
(Date:11/19/2009)...honored by latest award for revolutionary hearing ... November 16, 2009 -- Popular Science Magazine has...id from InSound Medical a winner of its coveted Be...y. Chosen from thousands of... hearing canal for up to four months while providi...
(Date:11/18/2009)...dotted postage stamp that can sniff out poisonous ..., As reported in the Sept. 13 issue of the journ...m at the University of Illinois have developed an ... industrial chemicals (TICs) that is simple, fast ...This sensor array could be useful in detecting hig...
(Date:11/18/2009)...x, U.K. and CLEVELAND, Nov. 18 TRE...ess and premier provider of diagnostic systems and...s expanded its East Grinstead, U.K., manufacturing...reasing global demand for its Sensititre® pro...sting. The expanded facility has been fully valida...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4...in Board: PLMO) announced today that it has increa...its total holdings to 61% in this Company,which ow... for pulmonary,related medical conditions., Pulmo...the Molecular,Imaging technology, developed and ow...the diagnosis of Pulmonary Embolism and Pulmonary ...
...emerging,leader in the development of implantable ...ations, announced today the addition of Jon Tremme...m Medtronic Inc. after nearly 30 years of service,...ncluding President of the,Neurological Division, P...,of the Tachyarrhythmia Management Division and Pr...
...ng costs drive solid ea...er Chilcott,Limited (Nasdaq: WCRX ) today announc...8. Revenue in the quarter ended March 31, 2008 tot... prior year quarter. The primary,drivers of the in...ed,products LOESTRIN 24 FE, DORYX, TACLONEX and FE...
Other Biology Technology:Pulmo BioTech Announces an Increase in its Stake in PulmoScience 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 3InSet Technologies Appoints Jon Tremmel to its Board of Directors 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17Mouse Anti-Human CCL26 / Eotaxin-3 Monoclonal Antibody, Unconjugated, Clone 115002 from R&D Systems
Goat Anti-Human TFPI Polyclonal Antibody, Unconjugated from R&D Systems
TMB Slow Kinetic One Component HRP Microwell Substrate from BioFX Laboratories, Inc.
Eppendorf tube holder, for Tube rack 175 x 12 mm from GE Healthcare, formerly Amersham Biosciences
Biology Products: